Survival analysis of carboplatin added to an anthracycline/taxane-based neoadjuvant chemotherapy and HRD score as predictor of response—final results from GeparSixto
Loibl, S., Weber, K.E., Timms, K.M., Elkin, E.P., Hahnen, E., Fasching, P.A., Lederer, B., Denkert, C., Schneeweiss, A., Braun, S., Salat, C.T., Rezai, M., Blohmer, J.U., Zahm, D.M., Jackisch, C., Gerber, B., Klare, P., Kümmel, S., Schem, C., Paepke, S., Schmutzler, R., Rhiem, K., Penn, S., Reid, J., Nekljudova, V., Hartman, A.-R., von Minckwitz, G., Untch, M.
Published in Annals of oncology (01.12.2018)
Published in Annals of oncology (01.12.2018)
Get full text
Journal Article
First-line atezolizumab plus nab-paclitaxel for unresectable, locally advanced, or metastatic triple-negative breast cancer: IMpassion130 final overall survival analysis
Emens, L.A., Adams, S., Barrios, C.H., Diéras, V., Iwata, H., Loi, S., Rugo, H.S., Schneeweiss, A., Winer, E.P., Patel, S., Henschel, V., Swat, A., Kaul, M., Molinero, L., Patel, S., Chui, S.Y., Schmid, P.
Published in Annals of oncology (01.08.2021)
Published in Annals of oncology (01.08.2021)
Get full text
Journal Article
A randomised phase II study investigating durvalumab in addition to an anthracycline taxane-based neoadjuvant therapy in early triple-negative breast cancer: clinical results and biomarker analysis of GeparNuevo study
Loibl, S., Untch, M., Burchardi, N., Huober, J., Sinn, B.V., Blohmer, J.-U., Grischke, E.-M., Furlanetto, J., Tesch, H., Hanusch, C., Engels, K., Rezai, M., Jackisch, C., Schmitt, W.D., von Minckwitz, G., Thomalla, J., Kümmel, S., Rautenberg, B., Fasching, P.A., Weber, K., Rhiem, K., Denkert, C., Schneeweiss, A.
Published in Annals of oncology (01.08.2019)
Published in Annals of oncology (01.08.2019)
Get full text
Journal Article
Primary results from IMpassion131, a double-blind, placebo-controlled, randomised phase III trial of first-line paclitaxel with or without atezolizumab for unresectable locally advanced/metastatic triple-negative breast cancer
Miles, D., Gligorov, J., Cameron, D., Xu, B., Semiglazov, V., Reinisch, M., Patre, M., Morales, L., Patel, S.L., Barata, T., Xu, B., Shao, Z., Wang, X., Geng, C., Yan, X., Tong, Z., Sun, T., Yang, J., Liu, Q., Zhang, S., De Laurentiis, M., Santoro, A., Colleoni, M., Cortesi, L., Placido, S., Ferrau, F., Del Mastro, L., Tonini, G., Montemurro, F., Bianchi, G., Prete, S., Allegrini, G., Naso, G., Vici, P., Loirat, D., Tredan, O., Gligorov, J., Timar David, M., Dohollou, N., Spano, J.-P., Mansi, L., Andrade, L., Damian, F., Aleixo, S., Junior, R., Reinisch, M., Grischke, E.-M., Harbeck, N., Peters, U., Fischer, D., Forstbauer, H., Warner, E., Bouganim, N., Vandenberg, T., Pavic, M., Robinson, A., Califaretti, N., Alacacioglu, A., Gumus, M., Yalcin, B., Cicin, I., Kose, F., Cubukcu, E., Wardley, A., Miles, D., Gupta, S., Mohapatra, P., Ghadyalpatil, N., Singhal, M., Agarwal, A., Wolf, I., Gal Yam, E., Yerushalmi, R., Peretz, T., Ben Baruch, N., Hamilton, E., Brufsky, A., Wright, G., Graff, S., Semiglazov, V., Ruiz Borrego, M., Merino, L., Guerra Martinez, J., Ohtani, S., Inoue, K., Ito, Y., Niikura, N., Sagara, Y., Yanagita, Y., Kaen, D., Nervo, A., Melichar, B., Sormova, P., Sufliarsky, J., Kakalejcik, M., Belbaraka, R., Errihani, H., Le Than, D., Pham, D., Papandreou, C.
Published in Annals of oncology (01.08.2021)
Published in Annals of oncology (01.08.2021)
Get full text
Journal Article
Pertuzumab plus trastuzumab in combination with standard neoadjuvant anthracycline-containing and anthracycline-free chemotherapy regimens in patients with HER2-positive early breast cancer: a randomized phase II cardiac safety study (TRYPHAENA)
Schneeweiss, A., Chia, S., Hickish, T., Harvey, V., Eniu, A., Hegg, R., Tausch, C., Seo, J.H., Tsai, Y.-F., Ratnayake, J., McNally, V., Ross, G., Cortés, J.
Published in Annals of oncology (01.09.2013)
Published in Annals of oncology (01.09.2013)
Get full text
Journal Article
Neoadjuvant durvalumab improves survival in early triple-negative breast cancer independent of pathological complete response
Loibl, S., Schneeweiss, A., Huober, J., Braun, M., Rey, J., Blohmer, J.-U., Furlanetto, J., Zahm, D.-M., Hanusch, C., Thomalla, J., Jackisch, C., Staib, P., Link, T., Rhiem, K., Solbach, C., Fasching, P.A., Nekljudova, V., Denkert, C., Untch, M.
Published in Annals of oncology (01.11.2022)
Published in Annals of oncology (01.11.2022)
Get full text
Journal Article
Neoadjuvant paclitaxel/olaparib in comparison to paclitaxel/carboplatinum in patients with HER2-negative breast cancer and homologous recombination deficiency (GeparOLA study)
Fasching, P.A., Link, T., Hauke, J., Seither, F., Jackisch, C., Klare, P., Schmatloch, S., Hanusch, C., Huober, J., Stefek, A., Seiler, S., Schmitt, W.D., Uleer, C., Doering, G., Rhiem, K., Schneeweiss, A., Engels, K., Denkert, C., Schmutzler, R.K., Hahnen, E., Untch, M., Burchardi, N., Blohmer, J.-U., Loibl, S.
Published in Annals of oncology (01.01.2021)
Published in Annals of oncology (01.01.2021)
Get full text
Journal Article
Tumor mutational burden and immune infiltration as independent predictors of response to neoadjuvant immune checkpoint inhibition in early TNBC in GeparNuevo
Karn, T., Denkert, C., Weber, K.E., Holtrich, U., Hanusch, C., Sinn, B.V., Higgs, B.W., Jank, P., Sinn, H.P., Huober, J., Becker, C., Blohmer, J.-U., Marmé, F., Schmitt, W.D., Wu, S., van Mackelenbergh, M., Müller, V., Schem, C., Stickeler, E., Fasching, P.A., Jackisch, C., Untch, M., Schneeweiss, A., Loibl, S.
Published in Annals of oncology (01.09.2020)
Published in Annals of oncology (01.09.2020)
Get full text
Journal Article
Can Routine Imaging After Neoadjuvant Chemotherapy in Breast Cancer Predict Pathologic Complete Response?
Schaefgen, B., Mati, M., Sinn, H. P., Golatta, M., Stieber, A., Rauch, G., Hennigs, A., Richter, H., Domschke, C., Schuetz, F., Sohn, C., Schneeweiss, A., Heil, Joerg
Published in Annals of surgical oncology (01.03.2016)
Published in Annals of surgical oncology (01.03.2016)
Get full text
Journal Article
The HER2 phenotype of circulating tumor cells in HER2-positive early breast cancer: A translational research project of a prospective randomized phase III trial
Jaeger, B A S, Neugebauer, J, Andergassen, U, Melcher, C, Schochter, F, Mouarrawy, D, Ziemendorff, G, Clemens, M, V Abel, E, Heinrich, G, Schueller, K, Schneeweiss, A, Fasching, P, Beckmann, M W, Scholz, Ch, Friedl, T W P, Friese, K, Pantel, K, Fehm, T, Janni, W, Rack, B
Published in PloS one (06.06.2017)
Published in PloS one (06.06.2017)
Get full text
Journal Article
MicroRNA-520/373 family functions as a tumor suppressor in estrogen receptor negative breast cancer by targeting NF-κB and TGF-β signaling pathways
Keklikoglou, I, Koerner, C, Schmidt, C, Zhang, J D, Heckmann, D, Shavinskaya, A, Allgayer, H, Gückel, B, Fehm, T, Schneeweiss, A, Sahin, Ö, Wiemann, S, Tschulena, U
Published in Oncogene (13.09.2012)
Published in Oncogene (13.09.2012)
Get full text
Journal Article
Patient-reported outcomes from the phase III IMpassion130 trial of atezolizumab plus nab-paclitaxel in metastatic triple-negative breast cancer
Adams, S., Diéras, V., Barrios, C.H., Winer, E.P., Schneeweiss, A., Iwata, H., Loi, S., Patel, S., Henschel, V., Chui, S.Y., Rugo, H.S., Emens, L.A., Schmid, P.
Published in Annals of oncology (01.05.2020)
Published in Annals of oncology (01.05.2020)
Get full text
Journal Article
Association of RAD51 with homologous recombination deficiency (HRD) and clinical outcomes in untreated triple-negative breast cancer (TNBC): analysis of the GeparSixto randomized clinical trial
Llop-Guevara, A., Loibl, S., Villacampa, G., Vladimirova, V., Schneeweiss, A., Karn, T., Zahm, D.-M., Herencia-Ropero, A., Jank, P., van Mackelenbergh, M., Fasching, P.A., Marmé, F., Stickeler, E., Schem, C., Dienstmann, R., Florian, S., Nekljudova, V., Balmaña, J., Hahnen, E., Denkert, C., Serra, V.
Published in Annals of oncology (01.12.2021)
Published in Annals of oncology (01.12.2021)
Get full text
Journal Article
nab-Paclitaxel plus carboplatin or gemcitabine versus gemcitabine plus carboplatin as first-line treatment of patients with triple-negative metastatic breast cancer: results from the tnAcity trial
Yardley, D.A., Coleman, R., Conte, P., Cortes, J., Brufsky, A., Shtivelband, M., Young, R., Bengala, C., Ali, H., Eakel, J., Schneeweiss, A., de la Cruz-Merino, L., Wilks, S., O’Shaughnessy, J., Glück, S., Li, H., Miller, J., Barton, D., Harbeck, N.
Published in Annals of oncology (01.08.2018)
Published in Annals of oncology (01.08.2018)
Get full text
Journal Article
Liquid Biopsy Response Evaluation Criteria in Solid Tumors (LB-RECIST)
Gouda, M.A., Janku, F., Wahida, A., Buschhorn, L., Schneeweiss, A., Abdel Karim, N., De Miguel Perez, D., Del Re, M., Russo, A., Curigliano, G., Rolfo, C., Subbiah, V.
Published in Annals of oncology (01.03.2024)
Published in Annals of oncology (01.03.2024)
Get full text
Journal Article
Changes in chemotherapy usage and outcome of early breast cancer patients in the last decade
Hennigs, A., Riedel, F., Marmé, F., Sinn, P., Lindel, K., Gondos, A., Smetanay, K., Golatta, M., Sohn, C., Schuetz, F., Heil, J., Schneeweiss, A.
Published in Breast cancer research and treatment (01.12.2016)
Published in Breast cancer research and treatment (01.12.2016)
Get full text
Journal Article
Recommendations from an international expert panel on the use of neoadjuvant (primary) systemic treatment of operable breast cancer: new perspectives 2006
Kaufmann, M., von Minckwitz, G., Bear, H.D., Buzdar, A., McGale, P., Bonnefoi, H., Colleoni, M., Denkert, C., Eiermann, W., Jackesz, R., Makris, A., Miller, W., Pierga, J.-Y., Semiglazov, V., Schneeweiss, A., Souchon, R., Stearns, V., Untch, M., Loibl, S.
Published in Annals of oncology (01.12.2007)
Published in Annals of oncology (01.12.2007)
Get full text
Journal Article
Dual HER2-blockade with pertuzumab and trastuzumab in HER2-positive early breast cancer: a subanalysis of data from the randomized phase III GeparSepto trial
Loibl, S., Jackisch, C., Schneeweiss, A., Schmatloch, S., Aktas, B., Denkert, C., Wiebringhaus, H., Kümmel, S., Warm, M., Paepke, S., Just, M., Hanusch, C., Hackmann, J., Blohmer, J.-U., Clemens, M., Dan Costa, S., Gerber, B., Engels, K., Nekljudova, V., von Minckwitz, G., Untch, M.
Published in Annals of oncology (01.03.2017)
Published in Annals of oncology (01.03.2017)
Get full text
Journal Article
Final efficacy and updated safety results of the randomized phase III BEATRICE trial evaluating adjuvant bevacizumab-containing therapy in triple-negative early breast cancer
Bell, R., Brown, J., Parmar, M., Toi, M., Suter, T., Steger, G.G., Pivot, X., Mackey, J., Jackisch, C., Dent, R., Hall, P., Xu, N., Morales, L., Provencher, L., Hegg, R., Vanlemmens, L., Kirsch, A., Schneeweiss, A., Masuda, N., Overkamp, F., Cameron, D.
Published in Annals of oncology (01.04.2017)
Published in Annals of oncology (01.04.2017)
Get full text
Journal Article
The 21-gene recurrence score assay impacts adjuvant therapy recommendations for ER-positive, node-negative and node-positive early breast cancer resulting in a risk-adapted change in chemotherapy use
Eiermann, W., Rezai, M., Kümmel, S., Kühn, T., Warm, M., Friedrichs, K., Schneeweiss, A., Markmann, S., Eggemann, H., Hilfrich, J., Jackisch, C., Witzel, I., Eidtmann, H., Bachinger, A., Hell, S., Blohmer, J.
Published in Annals of oncology (01.03.2013)
Published in Annals of oncology (01.03.2013)
Get full text
Journal Article